NRGene Technologies Ltd

Tel Aviv Stock Exchange NRGN.TA

NRGene Technologies Ltd EPS (Diluted) for the year ending December 31, 2023: USD -0.42

NRGene Technologies Ltd EPS (Diluted) is USD -0.42 for the year ending December 31, 2023, a 16.00% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • NRGene Technologies Ltd EPS (Diluted) for the year ending December 31, 2022 was USD -0.50, a 27.54% change year over year.
  • NRGene Technologies Ltd EPS (Diluted) for the year ending December 31, 2021 was USD -0.69, a -165.38% change year over year.
  • NRGene Technologies Ltd EPS (Diluted) for the year ending December 31, 2020 was USD -0.26, a 42.22% change year over year.
  • NRGene Technologies Ltd EPS (Diluted) for the year ending December 31, 2019 was USD -0.45, a 13.46% change year over year.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
Loading...
SV Wall Street
Tel Aviv Stock Exchange: NRGN.TA

NRGene Technologies Ltd

CEO Dr. Gil Ronen Ph.D.
IPO Date Jan. 31, 2021
Location Israel
Headquarters Golda Meir Street
Employees 50
Sector Consumers Staples
Industries
Description

NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.

StockViz Staff

February 6, 2025

Any question? Send us an email